Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

Recruiting now

Conditions studied: Malignant Solid Tumors, Primary Brain Tumor, Melanoma, Soft Tissue Sarcoma, Colorectal Cancer, Kidney Cancer, Prostate Cancer

In brief

The investigators will collect biosamples of patient blood and tumour tissue for further immunological analysis of blood cell subpopulations, immunosupressive factors concentration, HLA expression an lymphocytes and tumour tissue, and and cancer testis antigenes expression on tumour cells, as well as clinical data on patient's stage, therapy, response and demographics. Possible prognostic and predictive dynamic biomarkers will be discovered for individualisation of treatment strategies

Key facts

Study ID

NCT05539677

Run by

N.N. Petrov National Medical Research Center of Oncology

People needed

1000

Starts

1998-09-01

Expected to finish

2030-12-01

Last updated by the study team

2024-05-06

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed inform consent
• Histolgically verified solid tumour
• Receiving systemic therapy for neoplasm
• Has archival tumour tissue
• Provide biosamples with living tumour tissue or blood samples for immunologic assessment

You may not qualify if…

• Concurrent Lymphoprolipherative disorder
• Patients after stem cell or bone marrow thansplantation
• Incomplete informaton on previous cancer history or medical history
• Patients with known primary immunodeficiency
• Patients receiving immunosupressive therapy for concurrent illness
• Pregnant patients

Where it is running

• N.N. Petrov NMRC of Oncology, Oncoimmunology dep. — Saint Petersburg, Russia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.